Literature DB >> 14175212

[THE EFFICACY OF L-DOPA IN PARKINSON PATIENTS WITH AND WITHOUT STEREOTACTIC BRAIN SURGERY].

W UMBACH, D BAUMANN.   

Abstract

Entities:  

Keywords:  DOPA; NEUROSURGERY; PARKINSONISM; STEREOTAXIC TECHNICS

Mesh：

Substances：

Year:  1964        PMID： 14175212     DOI： 10.1007/BF00395715

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr        ISSN： 0003-9373


× No keyword cloud information.
  37 in total

1.  Dopamine metabolism in Parkinson's disease.

Authors:  M GREER; C M WILLIAMS
Journal:  Neurology       Date:  1963-01       Impact factor: 9.910

2.  Biochemistry of Parkinson's disease.

Authors:  A BARBEAU; G JASMIN; Y DUCHASTEL
Journal:  Neurology       Date:  1963-01       Impact factor: 9.910

3.  Effect of iproniazid on monoamines and monamine oxidase in human brain.

Authors:  P O GANROT; E ROSENGREN; C G GOTTFRIES
Journal:  Experientia       Date:  1962-06-15

4.  Localization of dopamine-beta-oxidase in brain.

Authors:  S UDENFRIEND; C R CREVELING
Journal:  J Neurochem       Date:  1959-10       Impact factor: 5.372

5.  [Monoamino-oxidase inhibitors].

Authors:  A PLETSCHER
Journal:  Dtsch Med Wochenschr       Date:  1961-04-07       Impact factor: 0.628

6.  The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice.

Authors:  H BLASCHKO; T L CHRUSCIEL
Journal:  J Physiol       Date:  1960-05       Impact factor: 5.182

7.  [Influence of aminoxydase inhibition on the effects of biogenic amines].

Authors:  H BALZER; P HOLTZ
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1956

8.  The oxidation of adrenaline and other amines.

Authors:  H Blaschko; D Richter; H Schlossmann
Journal:  Biochem J       Date:  1937-12       Impact factor: 3.857

9.  [Development and clinical aspect of methodical brain surgery].

Authors:  T RIECHERT; M WOLFF
Journal:  Med Klin       Date:  1951-05-25

10.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704
View more
  7 in total

1.  [ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Arch Psychiatr Nervenkr       Date:  1964-12-02

Review 2.  Monoamine reuptake inhibitors in Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox; Jonathan M Brotchie
Journal:  Parkinsons Dis       Date:  2015-02-25

Review 3.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

4.  [Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

Authors:  W Birkmayer; M Mentasti
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1967-08-08

5.  [Differential treatment of Parkinson's disease, with special reference to the possibility of iatrogenic disorders (author's transl)].

Authors:  W Gehlen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-04-09

Review 6.  The Human Experience with Intravenous Levodopa.

Authors:  Shan H Siddiqi; Natalia K Abraham; Christopher L Geiger; Morvarid Karimi; Joel S Perlmutter; Kevin J Black
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

7.  Levodopa: History and Therapeutic Applications.

Authors:  Sujith Ovallath; Bahiya Sulthana
Journal:  Ann Indian Acad Neurol       Date:  2017 Jul-Sep       Impact factor: 1.383
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.